Preparation and Characterization of Monensin Loaded PLGA Nanoparticles: In Vitro Anti-Malarial Activity Against Plasmodium Falciparum

被引:50
作者
Surolia, Ranu [1 ]
Pachauri, Manendra [1 ]
Ghosh, Prahlad Chandra [1 ]
机构
[1] Univ Delhi S Campus, Dept Biochem, New Delhi 110021, India
关键词
Malaria; Monensin; PLGA Nanoparticles; PLGA Molecular Weight; In Vitro Release; Antimalarial Efficacy; ARTEMISININ-RESISTANT MALARIA; POLYMER MOLECULAR-WEIGHT; DOUBLE EMULSION METHOD; RED-BLOOD-CELLS; BIODEGRADABLE NANOPARTICLES; PHYSICOCHEMICAL CHARACTERIZATION; IONOPHORE COMPOUNDS; DRUG-DELIVERY; RELEASE; LIPOSOMES;
D O I
10.1166/jbn.2012.1366
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
PLGA nanoparticles loaded with monensin (carboxylic ionophore) were prepared by emulsion solvent evaporation method using PLGA of molecular weight (Mw.) 19 000 and 110 000 Da. The nanoparticles were characterized by applying dynamic light scattering (DLS), atomic force microscopy (AFM), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR). Negatively charged and spherical smooth surfaced nanoparticles of size range between 147-167 nm were obtained. The nanoparticles of monensin-PLGA showed no chemical interaction between monensin and the polymer molecules. The release kinetics in vitro studies exhibited biphasic release profile characterized by an initial fast release followed by a slower release. The antimalarial efficacy of monensin-PLGA nanoparticles was also examined. Monensin loaded in nanoparticles was 10-fold more effective in inhibiting the growth of P. falciparum in vitro as compared to free monensin. The antimalarial efficacy of monensin-PLGA nanoparticles was significantly dependent on the Mw. of the polymer.
引用
收藏
页码:172 / 181
页数:10
相关论文
共 49 条
[1]   Monensin Induced Suicidal Erythrocyte Death [J].
Bhavsar, Shefalee K. ;
Eberhard, Matthias ;
Bobbala, Diwakar ;
Lang, Florian .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 25 (06) :745-752
[2]   Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (02) :205-214
[3]   Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content [J].
Budhian, Avinash ;
Siegel, Steven J. ;
Winey, Karen I. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (02) :367-375
[4]   Rhabdomyolysis, acute renal failure, and death after monensin ingestion [J].
Caldeira, C ;
Neves, WS ;
Cury, PM ;
Serrano, P ;
Baptista, MASF ;
Burdmann, EA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) :1108-1112
[5]  
Chambers E, 2007, EXP BIOL MED, V232, P958
[6]   Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles [J].
Date, Abhijit A. ;
Joshi, Medha D. ;
Patravale, Vandana B. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :505-521
[7]   QUANTITATIVE ASSESSMENT OF ANTI-MALARIAL ACTIVITY INVITRO BY A SEMIAUTOMATED MICRODILUTION TECHNIQUE [J].
DESJARDINS, RE ;
CANFIELD, CJ ;
HAYNES, JD ;
CHULAY, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (06) :710-718
[8]   Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro [J].
Ferdous, AJ ;
Stembridge, NY ;
Singh, M .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :71-78
[9]   Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity [J].
Fonseca, C ;
Simoes, S ;
Gaspar, R .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (02) :273-286
[10]  
Gaspar MM, 1998, J CONTROL RELEASE, V52, P53